{
  "id": "5d386d66a1e1595105000003",
  "type": "summary",
  "question": "What is the function of the SSX proteins?",
  "ideal_answer": "The SYT protein appears to act as a transcriptional co-activator and the SSX proteins as co-repressors",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/17667940",
    "http://www.ncbi.nlm.nih.gov/pubmed/10072425",
    "http://www.ncbi.nlm.nih.gov/pubmed/10739666",
    "http://www.ncbi.nlm.nih.gov/pubmed/20981248",
    "http://www.ncbi.nlm.nih.gov/pubmed/21880588",
    "http://www.ncbi.nlm.nih.gov/pubmed/17018603"
  ],
  "snippets": [
    {
      "text": "The SYT protein appears to act as a transcriptional co-activator and the SSX proteins as co-repressors",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10072425",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Taken together, these results led us to conclude that the SSX moiety, especially the most C-terminal 34 amino acids, of the SYT-SSX fusion proteins is crucial for aberrant spatial targeting and transcriptional control within the nucleus.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10739666",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17018603",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Together, we conclude that the SS18-SSX2 fusion protein may act as a so-called transcriptional \"activator-repressor,\" which induces downstream target gene deregulation through epigenetic mechanisms. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17018603",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Taken together, we conclude that this novel protein - protein interaction may have direct consequences for the (de)regulation of SSX and/or SS18-SSX target genes and, thus, for the development of human synovial sarcomas.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17667940",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The SSX family of cancer-testis antigens as target proteins for tumor therapy",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20981248",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Of particular interest among CTAs is the synovial sarcoma X chromosome breakpoint (SSX) family of proteins, which includes ten highly homologous family members. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20981248",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our findings suggest that multiple SSX family members are expressed in metastatic prostate cancers which are amenable to simultaneous targeting.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21880588",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}